Table 4 Exposure to therapy during pregnancy and outcome in 7 cases with low birth weight (<2500 g) newborns.
No of case | Therapy during pregnancy by trimester | Outcome | Week of gestation at birth | Gender | Birth weight, g | Percentilea | ||
|---|---|---|---|---|---|---|---|---|
1st trimester | 2nd trimester | 3rd trimester | ||||||
1 | – | – | – | Birth at term | 38 | Male | 2400 | <5 |
2 | – | – | – | Birth at term | 39 | Female | 2400 | <3 |
3 | – | PEG-IFN | PEG-IFN | Birth at term | 37 | Male | 2190 | <5 |
4 | – | IFN | Imatinib | Birth at term | 37 | Male | 2340 | <10 |
5 | – | Imatinib | Imatinib | Birth at term | 40 | Male | 2360 | <3 |
6 | – | Imatinib | Imatinib | Preterm birth | 35 | Female | 1700 | <3 |
7 | - | - | HC | Birth at term | 41 | female | 2400 | < 3 |
